Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-15 11:35 am Unchanged |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 6,995,861 8.400% |
0 (Unchanged) |
Filing History |
| 2024-02-15 09:15 am Unchanged |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 6,995,861 8.400% |
0 (Unchanged) |
Filing History |
| 2024-02-14 8:02 pm Purchase |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 6,995,861 8.400% |
811,000 (+13.11%) |
Filing History |
| 2024-02-14 7:54 pm Sale |
2023-12-31 | 13G | Morphic Holding, Inc. MORF |
EcoR1 Capital LLC | 211,262 0.400% |
-3,740,304 (-94.65%) |
Filing History |
| 2024-02-14 6:59 pm Purchase |
2023-12-31 | 13G | Zymeworks Inc. ZYME |
EcoR1 Capital LLC | 14,132,291 19.990% |
694,818 (+5.17%) |
Filing History |
| 2024-02-14 6:54 pm Unchanged |
2023-12-31 | 13G | Xencor, Inc. XNCR |
EcoR1 Capital LLC | 5,282,516 8.700% |
0 (Unchanged) |
Filing History |
| 2024-02-14 6:49 pm Sale |
2023-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
EcoR1 Capital LLC | 0 0.000% |
-1,052,810 (Position Closed) |
Filing History |
| 2024-02-14 6:45 pm Purchase |
2023-12-31 | 13G | Third Harmonic Bio, Inc. THRD |
EcoR1 Capital LLC | 3,182,444 7.900% |
200,000 (+6.71%) |
Filing History |
| 2024-02-14 6:41 pm Sale |
2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
EcoR1 Capital LLC | 0 0.000% |
-3,460,208 (Position Closed) |
Filing History |
| 2024-02-14 6:30 pm Sale |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
EcoR1 Capital LLC | 132,579 0.100% |
-7,066,121 (-98.16%) |
Filing History |
| 2024-02-14 6:19 pm Purchase |
2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 6,275,210 8.900% |
2,857,142 (+83.59%) |
Filing History |
| 2024-02-14 6:12 pm Sale |
2023-12-31 | 13G | NGM Biopharmaceuticals, Inc. NGM |
EcoR1 Capital LLC | 2,385,873 2.900% |
-4,049,645 (-62.93%) |
Filing History |
| 2024-02-14 6:05 pm Purchase |
2023-12-18 | 13G | Neurogene Inc. NGNE |
EcoR1 Capital LLC | 1,282,168 9.990% |
1,282,168 (New Position) |
Filing History |
| 2024-02-14 5:58 pm Purchase |
2023-12-31 | 13G | Kura Oncology, Inc. KURA |
EcoR1 Capital LLC | 7,598,797 9.990% |
960,426 (+14.47%) |
Filing History |
| 2024-02-14 5:53 pm Sale |
2023-12-31 | 13G | Janux Therapeutics, Inc. JANX |
EcoR1 Capital LLC | 0 0.000% |
-3,255,270 (Position Closed) |
Filing History |
| 2024-02-14 5:47 pm Sale |
2023-12-31 | 13G | HOOKIPA Pharma Inc. HOOK |
EcoR1 Capital LLC | 459,502 4.800% |
-37,847 (-7.61%) |
Filing History |
| 2024-02-14 5:41 pm Unchanged |
2023-12-31 | 13G | Galapagos NV GLPG |
EcoR1 Capital LLC | 6,505,890 9.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 5:37 pm Purchase |
2023-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
EcoR1 Capital LLC | 5,618,779 5.800% |
386,500 (+7.39%) |
Filing History |
| 2024-02-14 5:24 pm Purchase |
2023-12-31 | 13G | Arvinas, Inc. ARVN |
EcoR1 Capital LLC | 6,800,493 9.990% |
3,677,193 (+117.73%) |
Filing History |
| 2024-02-14 5:18 pm Purchase |
2023-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
EcoR1 Capital LLC | 11,173,068 9.400% |
4,865,521 (+77.14%) |
Filing History |